Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06828770 · ClinicalTrials.gov registry record

Minima Stent System Post- Approval Study (PAS)

A clinical trial of Pulmonary Artery Stenosis and Aortic Coarctation, sponsored by Renata Medical.

Recruiting
Registry status
100
Enrollment target
15
Study locations

NCT06828770: Recruiting study of Pulmonary Artery Stenosis and Aortic Coarctation, sponsored by Renata Medical.

NCT06828770 is a study of Pulmonary Artery Stenosis and Aortic Coarctation that is actively recruiting participants, run by Renata Medical. The registered enrollment target is 100 participants. The trial reports 15 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06828770, a study of Pulmonary Artery Stenosis and Aortic Coarctation, is actively recruiting participants, sponsored by Renata Medical.

RECRUITING
Registry status
100 participants
Enrollment target
15
Study locations

Study Summary

This Post-Approval Study is a single arm, prospective, multi-center, open-label study of patients treated with the Renata Minima Stent System in the United States. The objective of the study is to continue the assessment of device performance and capture outcome data on use of the device in real-world use.

Primary Outcome

Rate of Acute device success as defined by: * Stenosis relief, defined by stent outer diameter ≥ 75% of the normal surrounding vessel immediately after deployment. * Freedom from open surgical intervention required to treat Minima Stent dysfunction at implantation

Interventions

  • DEVICE Minima Stent System

Study Locations (15)

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati
  • Nationwide Children's Hospital - Columbus

Texas

  • Dell Children's Medical Center, The University of Texas at Austin - Austin
  • Columbia Hospital at Medical City Dallas Hospital - Dallas

California

  • Children's Hospital Los Angeles - Los Angeles

Colorado

  • Children's Hospital Colorado - Aurora

Florida

  • Nicklaus Children's Hospital - Miami

Georgia

  • Children's Healthcare of Atlanta - Atlanta

Illinois

  • Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago

Indiana

  • Riley Hospital for Children at Indiana University Health - Indianapolis

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-05-21
Est. Completion 2031-12
Renata Medical

2 total trials

What NCT06828770 shows while recruiting

NCT06828770 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 2 conditions, with Pulmonary Artery Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Minima Stent System is the first listed.

NCT06828770 lists 15 locations in 13 states (Ohio, Texas, California).

Frequently Asked Questions

What is clinical trial NCT06828770 about?

NCT06828770 is a clinical study titled "Minima Stent System Post- Approval Study (PAS)". This Post-Approval Study is a single arm, prospective, multi-center, open-label study of patients treated with the Renata Minima Stent System in the United States. The objective of the study is to continue the assessment of device performance and capture outcome data on use of the device in real-wor...

What is the current status of trial NCT06828770?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-05-21. Estimated completion is 2031-12.

What conditions does trial NCT06828770 study?

This clinical trial studies the following conditions: Pulmonary Artery Stenosis, Aortic Coarctation.

What interventions are being tested in trial NCT06828770?

The interventions under investigation include: Minima Stent System (DEVICE).

Who is sponsoring clinical trial NCT06828770?

This trial is sponsored by Renata Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06828770 being conducted?

This trial has 15 study locations across California, Colorado, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pulmonary Artery Stenosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06828770, the US trial registry maintained by the National Library of Medicine. NCT06828770 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.